Phosphatidylinositol 3-kinase and Akt protein kinase mediate IGF-I- and prosaptide-induced survival in Schwann cells

Journal of Neuroscience Research

Volumn 57, Issue 3, 1999, Pages 332-341

  Campana, W Marie ^a   Darin, Sam J ^b   O'Brien, John S ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Myelos Neurosciences   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Cell death; Extracellular regulated kinases (ERKs); Prosaposin; Saposin; Signaling

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; DNA FRAGMENT; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROSAPOSIN; PROTEIN KINASE; SOMATOMEDIN C; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL SURVIVAL; NERVE CELL CULTURE; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SCHWANN CELL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANALYSIS OF VARIANCE; ANIMALS; CELL SURVIVAL; CULTURE MEDIA, SERUM-FREE; ENZYME INHIBITORS; INSULIN-LIKE GROWTH FACTOR I; NERVE GROWTH FACTORS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SCHWANN CELLS; SIGNAL TRANSDUCTION;

EID: 0033179450     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990801)57:3<332::AID-JNR5>3.0.CO;2-0     Document Type: Article

References (51)

1. Anderson KE, Coadwell J, Stephens LR, Hawkins PT. 1998. Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B. Curr Biol 8:684-691.
2. Assouline JG, Bosch EP, Lim R. 1989. Purification of rat Schwann cells from cultures of peripheral nerve. In: Shahar A, de Vellis J, Vernadakis A, Haber B, editors. A dissection and tissue culture manual of the nervous system. New York: Wiley-Liss, Inc. p 247-250.
3. Barres BA, Raff MC. 1994 Control of oligodendrocyte number in the developing rat optic nerve. Neuron 12:935-942.
4. Bondeva T, Pirola L, Bulgarelli-Leva G, Rubio I, Wetzker R, Wymann MP. 1998. Bifurcation of lipid and protein kinase signals of PI3K to the protein kinases PKB and MAPK. Science 282:293-295.
5. Bondy CA. 1991. Transient IGF-I gene expression during the maturation of functionally related central projection neurons. J Neurosci 11:3442-3455.
6. Campana WM, Hiraiwa M, Addison KC, O'Brien JS. 1996. Induction of MAPK phosphorylation by prosaposin and prosaptide in PC12 cells. Biochem Biophys Res Commun 229:706-712.
7. Campana WM, Hiraiwa M, O'Brien JS. 1998. Prosaptide activates the MAPK pathway by a G-protein-dependent mechanism essential for enhanced sulfatide synthesis by Schwann cells. FASEB J 12:307-314.
8. Cheng CM, Joncas G, Reinhardt RR, Farrer R, Quarles R, Janssen J, McDonald MP, Crawley JN, Powell-Braxton L, Bondy CA. 1998. Biochemical and morphometric analyses show that myelination in the insulin-like growth factor-1 null brain is proportionate to its neuronal composition. J Neurosci 18:5673-5681.
9. Crowder RJ, Freeman RS. 1998. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor dependent sympathetic neurons. J Neurosci 18:2933-2943.
10. Datta K, Bellacosa A, Chan TO, Tsichlis PN. 1996. Akt is a direct target of the phosphatidylinositol 3-kinase. Activation by growth factors v-Src and v-Ha-ras in Sf9 and mammalian cells. J Biol Chem 271:30835-30839.
11. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241.
12. Dong Z, Brennana A, Liu N, Yarden Y, Lefkowitz G, Mirsky R, Jessen KR. 1995. Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors. Neuron 15:585-596.
13. Dudek H, Datta SR, Franke TF, Birnbaum, MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME. 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275:661-665.
14. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7689.
15. Ekström PA. 1995. Neurones and glial cells of the mouse sciatic nerve undergo apoptosis after injury in vivo and in vitro. NeuroReport 6:1029-1032.
16. Franke TF, Yang S, Chan TO, Datta K, Kazlauskas A, Morrison, DK, Kaplan DR, Tsichlis PN. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727-736.
17. Fujita N, Suzuki K, Vanier MT, Popko B, Maeda N, Klein A, Henseler M, Sandhoff K, Nakayasu H. 1996. Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Human Mol Genet 5:711-725.
18. Gardner A, Johnson G. 1996. Fibroblast growth factor-2 suppression of tumor necrosis factor alpha mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J Biol Chem 271:14560-14566.
19. Gavrilovic J, Brennan A, Mirsky R, Jessen KJ. 1995. Fibroblast growth factors and insulin like growth factors combine to promote survival of rat Schwann cells precursors without induction of DNA synthesis. Eur J Neurosci 7:77-85.
20. Grinspan JB, Marchionni MA, Reeves M, Coulaloglou M, Scherer SS. 1996. Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins. J Neurosci 16:6107-6118.
21. Harzer K, Paton BC, Poulos A, Kustermann-Kuhn B, Roggendorf W, Grisar T, Popp M. 1989. Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphigolipidoses. Eur J Pediatr 149:31-39.
22. Hiraiwa M, O'Brien JS, Kishimoto Y, Galdzicka M, Fluharty AJ, Ginns EF, Martin BM. 1993. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins). Arch Biochem Biophys 304:110-116.
23. Hiraiwa M, Campana, WM, Martin BM, O'Brien JS. 1997a. Prosaposin receptor: Evidence for a G-protein-associated receptor. Biochem Biophys Res Commun 240:415-418.
24. Hiraiwa M, Taylor EM, Campana WM, Darin SJ, O'Brien JS. 1997b. Cell death prevention, mitogen-activated protein kinase stimulation and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides. Proc Natl Acad Sci USA 94:4778-4781.
25. Hiraiwa M, Campana WM, Mizisin AP, Mohiuddin L, O'Brien JS. 1999. Prosaposin: a myelinotrophic protein that promotes expression of myelin constituents and is secreted after nerve injury. Glia 26:353-360.
26. Jessen KR, Brennan A, Morgan L, Mirsky R, Kent A, Hashimoto Y, Gavrilovic J. 1994. The Schwann cell precursor and its fate: a study of cell death and differentiation during gliogenesis in the rat embryonic nerves. Neuron 12:509-527.
27. Kopp DM, Trachtenberg JT, Thompson WJ. 1997. Glial growth factor rescues Schwann cells of mechanoreceptors from denervation-induced apoptosis. J Neurosci 17:6697-6706.
28. Kotani Y, Matsuda S, Wen TC, Sakanaka M, Tanaka I, Maeda N, Kondoh K, Ueno S, Sano A. 1996. A hydrophillic peptide comprising 18 amino acid residues of the prosaposin sequence has neurotrophic activity in vitro and in vivo. J Neurochem 66:2197-2200.
29. Madar-Shapiro L, Pasmanik-Chor M, Vaccaro AM, Dinur T, Dagan A, Gatt S, Horowitz M. 1999. Importance of splicing for prosaposin sorting. Biochem J 337:433-443.
30. Morimoto S, Yamamoto Y, O'Brien JS, Kishimoto Y. 1990. Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases. Anal Biochem 190:154-157.
31. Nakao J, Shinoda J, Nakai, Y, Murase S, Uyemura K. 1997. Apoptosis regulates the number of Schwann cells at the premyelinating stage. J Neurochem 68:1853-1862.
32. O'Brien JS, Kishimoto Y. 1991. Saposin proteins: structure, function, and role in human lysosomal storage disorders. FASEB J 5:301-308.
33. O'Brien JS, Carson GS, Seo H-C, Hiraiwa M, Kishimoto Y. 1994. Identification of prosaposin as a neurotrophic factor. Proc Natl Acad Sci USA 91:9593-9596.
34. O'Brien JS, Carson GS, Seo H-C, Hiraiwa M, Weiler S, Tomich JM, Barranger JA, Kahn M, Azuma N, Kishimoto Y. 1995. Identification of the neurotrophic factor sequence of prosaposin. FASEB J 9:681-685.
35. Parrizas M, Saltiel AR, LeRoith D. 1997 Insulin-like growth factor-1 inhibits apoptosis using the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathway. J Biol Chem 272:154-161.
36. Philpott KL, McCarthy MJ, Klippel A, Rubin LL. 1997. Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons. J Cell Biol 139:809-815.
37. Qi X, Qin W, Sun Y, Kondoh K, Grabowski G. 1996. Functional organization of saposin C. Definition of the neurotrophic and acid beta-glucosidase activation regions. J Biol Chem 271:6874-6880.
38. Raff MC. 1992. Social controls on cell survival and cell death. Nature 356:397-399.
39. Schnabel D, Schrodert M, Furst W, Klein A, Hurwitz R, Zenk T, Weber J, Harzer K, Paton B C, Poulos A, Suzuki K, Sandhoff K. 1992. Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the iniation codon of their common gene. J Biol Chem 267:3312-3315.
40. Stephens L, Eguinoa A, Corey S, Jackson T, Hawkins PT. 1993. Receptor stimulated accumulation of phoshatidylinositol (3,4,5)-triphosphate by G-protein mediated pathways in human myeloid derived cells. EMBO J 12:2265-2273.
41. Stewart HJ, Bradke F, Tabernero A, Morrell D, Jessen KR, Mirsky R. 1996. Regulation of rat Schwan cell P0 expression and DNA synthesis by insulin-like growth factors in vitro. Eur J Neurosci 8:553-564.
42. Syroid DE, Zorick TS, Arbet-Engels C, Kilpatrick TJ, Eckhart W, Lemke G. 1999. A role for insulin-like growth factor-I in the regulation of Schwann cell survival. J Neurosci 19:2059-2068.
43. Trachtenberg JT, Thompson WJ. 1996. Schwann cell apoptosis at developing neuromuscular junction is regulated by glial growth factor. Nature 379:174-177.
44. Ullrich A, Schlessinger J. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212.
45. Vemuri GS, McMorris FA. 1996. Oligodendrocytes and their precursors require phosphatidylinositol 3-kinase signaling for survival. Development 122:2529-2537.
46. Vlahos CJ, Matter MF, Hui KY, Brown RF. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269:5241-5248.
47. Woods KA, Comacho-Hubner C, Savage MO, Clark AJL. 1996. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor gene. N Engl J Med 335:1363-1367.
48. Xia Z, Dickens M, Raingeaud J, Davis R, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
49. Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y, Nonomura Y, Matsuda Y. 1993. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J Biol Chem 268:25846-25856.
50. Yao R, Cooper GM. 1995. Requirement for phosphatidylinositol 3-kinase in the prevention of apoptosis by nerve growth factor. Science 267:2003-2006.
51. L. Cell 87:619-628.